Subscribe To
Fda staff report says data shows pfizer's covid treatment paxlovid is effective in high-risk adults
FDA staff said Pfizer's clinical trial results on its Covid antiviral pill Paxlovid support its use in adults ...
March 14, 2023, 3:04 pm
5 etfs to make the most of march madness betting
About one-quarter of all American adults are poised to collectively bet $15.5 billion on this year's NC...
March 13, 2023, 12:13 pm
Acadia's rare-disease drug to cost $575,000 to $595,000
Acadia Pharmaceuticals Inc. ACAD said its newly approved treatment for Rett syndrome has an annual list price ranging from $575,000 to $595,000, accor...
March 13, 2023, 12:11 pm
Pfizer wins fda approval for its migraine nasal spray
Pfizer Inc. PFE, -1.65% said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first a...
March 10, 2023, 6:54 am
Springworks therapeutics announces new england journal of medicine publication of phase 3 defi trial evaluating nirogacestat in adults with desmoid tumors
– Nirogacestat Treatment Significantly Improved Progression-Free Survival, Objective Response Rate and Key Patient Reported Outcomes – – New Dru...
March 8, 2023, 10:05 pm
Lilly's drug aimed at preventing alzheimer's fails
Eli Lilly & Co. said late Wednesday that a drug aimed at preventing Alzheimer's disease before symptoms start has failed to slow down cognitive declin...
March 8, 2023, 5:54 pm
Merck (mrk) reports detailed data from pah study on sotatercept
Merck & Co. (MRK) announces detailed data from the phase III STELLAR study of sotatercept for the treatment of pulmonary arterial hypertension in adul...
March 8, 2023, 9:02 am
Pfizer (pfe) or gsk: who will get the first fda nod for rsv jab?
An FDA advisory committee recommended approving Pfizer's (PFE) and GSK's respective RSV vaccines for older adults. Currently, there are no RSV vaccine...
March 7, 2023, 12:02 pm
Fda now set to decide on biomarin's hemophilia drug by june 30
BioMarin Pharmaceutical Inc. BMRN, -6.82% said Tuesday that the Food and Drug Administration pushed back the deadline to make a decision whether to ap...
March 7, 2023, 7:42 am
Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (csu) in adults and adolescents aged 12 years and older accepted for fda review
More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by antihistamines TARRYTOWN, N.Y. and PARIS, March 07, 2023 (GLOB...
March 7, 2023, 6:00 am
Banking the unbanked with cryptocurrency: risks and rewards
According to the World Bank, over 1.7 billion adults around the world do not have access to traditio...
March 6, 2023, 5:01 pm
How some gen z instagram users post to facebook: unwittingly
Teenagers and young adults are flummoxed. The reason it keeps happening involves an online prompt and p...
March 6, 2023, 10:58 am
Time us adults spend on tiktok closes in on netflix: market tracker
TikTok is closing in on streaming giant Netflix when it comes to the amount of time US adults spend on ...
March 3, 2023, 7:57 am
Praxis: shaking the dust off calcium channel blockers for essential tremor
Praxis Precision Medicines' ulixacaltamide (PRAX-944) is a potent and selective small molecule T-type Ca2+ channel blocker being developed for the pot...
March 3, 2023, 2:26 am
Unity care expands its transitional housing services for youth to monterey county area
San Jose-based organization Unity Care has recently announced its expansion into Monterey County, California, in order to provide supportive housing t...
March 2, 2023, 8:11 pm
Gsk neck and neck with pfizer in the race to get first rsv jab to market
GSK PLC (LSE:GSK, NYSE:GSK)'s respiratory syncytial virus (RSV) vaccine has been endorsed by advisors to the US Food & Drug Administration, who assess...
March 2, 2023, 5:19 am
Fda advisors recommend gsk's rsv vaccine for older adults, but flag potential safety risks
The Food and Drug Administration's independent panel of advisors on Wednesday recommended GlaxoSmithKline's RSV vaccine for ...
March 1, 2023, 2:33 pm
Reata pharmaceuticals wins key fda approval for rare disease treatment friedreich's ataxia, sending shares soaring
Biopharma company Reata Pharmaceuticals Inc (NASDAQ:RETA) was in the spotlight on Wednesday after a key approval from the US Food and Drug Administra...
March 1, 2023, 12:23 pm
Pfizer takes lead in the race to be first with rsv jab
Pfizer Inc (NYSE:PFE)'s respiratory syncytial virus (RSV) vaccine has moved a step closer to being approved in the United States for older ...
March 1, 2023, 2:56 am
Pfizer gets fda panel’s backing in rsv vaccine race
By Khushi Mandowara and Mariam ESunny (Reuters) – A panel of outside advisers to the U.S. health regulator on Tuesday recommended Pfizer Inc’s res...
March 1, 2023, 12:06 am